Hillhouse Investment Management’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-352,300
Closed -$6.36M 58
2017
Q2
$6.36M Buy
+352,300
New +$6.36M 0.1% 44